Back
Catalyst Pharmaceuticals Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
21.28
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Catalyst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.4% based on the past 17 years of stock performance.
- Catalyst Pharmaceuticals has risen higher in 10 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
-
Is Catalyst Pharmaceuticals Stock Undervalued?
The current Catalyst Pharmaceuticals [CPRX] share price is $21.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.4% based on the past 17 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals overpriced?
- Catalyst Pharmaceuticals has risen higher in 10 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
24.27
52-Week Low:
13.00
Prediction Charts
Market Cap:
2.52B
Price in USD:
21.12
Volume:
807.5K
Beta:
1.10
Technical Analysis
SMA50:
21.09
SMA100:
19.61
SMA200:
17.53
52-Wk Change:
53.71%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?
Yes, Catalyst Pharmaceuticals is a publicly traded company. -
What is the Catalyst Pharmaceuticals stock quote today?
The Catalyst Pharmaceuticals stock price is 21.12 USD today. -
How to buy Catalyst Pharmaceuticals stock online?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 21.82 | 21.74 | 21.96 | 21.30 |
| Nov-5 | 21.57 | 21.96 | 22.05 | 21.41 |
| Nov-6 | 22.77 | 22.74 | 23.12 | 22.60 |
| Nov-7 | 24.21 | 23.25 | 24.21 | 23.02 |
| Nov-8 | 23.50 | 23.93 | 24.27 | 23.37 |
| Nov-11 | 24.10 | 23.43 | 24.11 | 23.22 |
| Nov-12 | 23.45 | 23.04 | 23.73 | 22.99 |
| Nov-13 | 23.18 | 22.80 | 23.50 | 22.80 |
| Nov-14 | 22.76 | 21.69 | 22.78 | 21.52 |
| Nov-15 | 21.51 | 20.60 | 21.63 | 20.44 |
| Nov-18 | 20.76 | 20.82 | 21.19 | 20.53 |
| Nov-19 | 20.81 | 21.39 | 21.39 | 20.76 |
| Nov-20 | 21.52 | 21.15 | 21.63 | 21.05 |
| Nov-21 | 21.21 | 21.12 | 21.21 | 20.87 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.